ADHD

Scientists have uncovered an odd superpower triggered by tapping your finger to a beat – it may help you understand someone talking to you in a noisy place, like at a busy cafe. While it sounds a little woo-woo, there's emerging science behind it.

A landmark clinical trial testing the effect of microdosing LSD on symptoms of ADHD recently delivered its first data readout and the results have been surprising, to say the least, raising questions over the efficacy of this popular trend.

A decade-spanning study has revealed a troubling side effect when pregnant women take a common painkiller during their pregnancies. The effect of the over-the-counter drug was significantly stronger in female offspring than males.

What happens in your brain when you listen to your favorite music? Can hearing a nostalgic song from your youth actually improve your cognitive health and help fight off conditions like Alzheimer's? Several neuroscientists are trying to find out.

In the first study of its kind, scientists have used extensive data to identify that adults with ADHD have a significantly lower life expectancy than their neurotypical peers. This unprecedented research should serve as a serious wake-up call.

After recording kids copying the dance moves of an on-screen avatar for just a minute, an innovative tool can accurately distinguish neurotypical children from those with autism. It can even tell autism from ADHD, conditions that commonly overlap.

We've never been closer to accurately assessing whether someone is more susceptible to developing depression due to their biology, with 293 new gene variants found to play a role in ramping up the risk factor. That's 42% more than previously known.

New research has found that an existing ADHD medication greatly reduced the number of days people with a methamphetamine dependence used the drug. With no current drug treatment to assist people in getting off meth, the study’s findings are promising.

In a massive analysis of 113 clinical trials involving nearly 15,000 adults, researchers found that there's just one method that relieves core symptoms of attention-deficit/hyperactivity disorder – but no existing treatment improves quality of life.

People with disabilities face many obstacles navigating the workforce, and for the neurodiverse population, having conditions that can 'hide in plain sight' present unique challenges. This initiative wants to change it – whether it works, is another thing.

Spanning nearly 100 laboratories in 45 countries, a landmark study has, for the first time, shown an association between genetic brain shape and size and the prevalence of neurological conditions such as Parkinson's disease and ADHD.

A non-invasive brain-computer interface that produces real-time EEG feedback on neural activity while the user plays a video-game, and then assesses data with AI, is helping clinicians more accurately diagnose attention-deficit/hyperactivity disorder.